T Cell Dysfunction In Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
T-cell dysfunction represents an emerging area of research in neurodegenerative diseases, linking peripheral immune alterations to central nervous system pathology. While [microglia](/entities/microglia) are the resident immune cells of the brain, accumulating evidence demonstrates that T-cells—a component of the adaptive immune system—play crucial roles in neuroinflammation, disease progression, and potential therapeutic targeting across Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS)[^1][^2].
The immune system undergoes significant changes during aging and neurodegeneration. T-cells, which coordinate adaptive immune responses, have been shown to infiltrate the brain parenchyma in various neurodegenerative conditions[^3]. These infiltrating T-cells interact with [microglia](/cell-types/microglia) and other immune cells, modulating neuroinflammatory responses that contribute to neuronal dysfunction and death.
T Cell Dysfunction In Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
T-cell dysfunction represents an emerging area of research in neurodegenerative diseases, linking peripheral immune alterations to central nervous system pathology. While [microglia](/entities/microglia) are the resident immune cells of the brain, accumulating evidence demonstrates that T-cells—a component of the adaptive immune system—play crucial roles in neuroinflammation, disease progression, and potential therapeutic targeting across Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS)[^1][^2].
The immune system undergoes significant changes during aging and neurodegeneration. T-cells, which coordinate adaptive immune responses, have been shown to infiltrate the brain parenchyma in various neurodegenerative conditions[^3]. These infiltrating T-cells interact with [microglia](/cell-types/microglia) and other immune cells, modulating neuroinflammatory responses that contribute to neuronal dysfunction and death.
The discovery of functional lymphatic vessels in the dura mater has revolutionized our understanding of how T-cells traffic between the central nervous system (CNS) and peripheral immune system[^1]. This glymphatic-lymphatic system provides a anatomical basis for immune cell surveillance and neuroimmune communication.
CD4+ T-cells differentiate into various subsets that exert distinct effects on neuroinflammation:
CD8+ T-cells can directly kill [neurons](/entities/neurons) and glial cells through perforin and granzyme release. In AD brains, CD8+ T-cells are found in close proximity to amyloid plaques, and their presence correlates with cognitive decline[^6]. In PD, CD8+ T-cells have been shown to attack dopaminergic neurons expressing MHC-I antigens[^7].
Systemic inflammation in aging and neurodegeneration leads to T-cell activation through multiple pathways:
Activated T-cells release cytokines that modulate microglial activation states:
T-cells enter the CNS through multiple mechanisms:
In AD, T-cell abnormalities include:
PD exhibits:
ALS shows:
MS is fundamentally an autoimmune disease where T-cells:
Targeting T-cell dysfunction offers therapeutic potential:
Emerging approaches include:
Peripheral T-cell parameters show promise as disease biomarkers:
The study of T Cell Dysfunction In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Recent advances have expanded our understanding of T-cell dysfunction in neurodegeneration:
[^2] Kipanyula MJ,註更多基於T細胞的阿茲海默症免疫療法：當前知識與未來展望. Front Immunol. 2022;13:897841. [DOI:10.3389/fimmu.2022.897841](https://doi.org/10.3389/fimmu.2022.897841)
[^3] Bae JY, Lee J, Shin KO. Peripheral and central innate immune cells in the pathogenesis of neurodegenerative diseases. Int J Mol Sci. 2023;24(8):7632. [DOI:10.3390/ijms24087632](https://doi.org/10.3390/ijms24087632)
[^4] Chen WW, Zhang X, Huang WJ. Role of Th1/Th2 cytokines in the pathogenesis of Alzheimer's disease. Exp Ther Med. 2021;22(4):1106. [DOI:10.3892/etm.2021.10547](https://doi.org/10.3892/etm.2021.10547)
[^5] Roszer T. Understanding the biology of the aging neurogenic niche and its implication for neurodegeneration. Neural Regen Res. 2021;16(2):261-270.
[^6] Mercier MR, Bati J, Orme J, et al. Myeloid and CD8+ T cells in Alzheimer's disease. Nat Aging. 2022;2:896-905. [DOI:10.1038/s43587-022-00286-4](https://doi.org/10.1038/s43587-022-00286-4)
[^7] Jiang S, Chan L, Miao X, et al. CD8+ T-cells in Parkinson's disease: Pathogenic role and therapeutic potential. Cell Mol Neurobiol. 2023;43(5):1897-1911. [DOI:10.1007/s10571-023-01311-1](https://doi.org/10.1007/s10571-023-01311-1)
[^8] Stuendl A, Kunadt M, Kruse N, et al. Induction of a regenerative microenvironment in the brain by systemic immunotherapy. Brain. 2021;144(6):1692-1706. [DOI:10.1093/brain/awab067](https://doi.org/10.1093/brain/awab067)
🔴 Low Confidence
| Dimension | Score |
|-----------|-------|
| Supporting Studies | 0 references |
| Replication | 0% |
| Effect Sizes | 50% |
| Contradicting Evidence | 0% |
| Mechanistic Completeness | 75% |
Overall Confidence: 30%
[@recent2024]: [Reference missing - citation needed]
[@recent2024a]: [Reference missing - citation needed]
[@recent2024b]: [Reference missing - citation needed]
[@recent2024c]: [Reference missing - citation needed]